scholarly article | Q13442814 |
P50 | author | Banchob Sripa | Q30004087 |
P2093 | author name string | Masanao Miwa | |
Narong Khuntikeo | |||
Temduang Limpaiboon | |||
Patcharee Jearanaikoon | |||
Vajarabhongsa Bhudhisawasdi | |||
Jongkonnee Thanasai | |||
P2860 | cites work | Genetic aberrations detected by comparative genomic hybridization in biliary tract cancers | Q77961970 |
Genomic amplification of orthodenticle homologue 2 in medulloblastomas | Q24294737 | ||
BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria | Q28205892 | ||
Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma | Q30396926 | ||
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression | Q33707642 | ||
Intrahepatic cholangiocarcinoma in Thailand | Q33845493 | ||
Cancer control in Thailand | Q33958636 | ||
Expression of ST13 in colorectal cancer and adjacent normal tissues | Q34382223 | ||
Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream | Q34683632 | ||
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay | Q35842067 | ||
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression | Q35951880 | ||
Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. | Q36080231 | ||
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions | Q38455863 | ||
Increased expression of thymidine phosphorylase in tumor tissue in proportion to TP-expression in primary normal tissue | Q39078551 | ||
Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). | Q41660744 | ||
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver | Q43086184 | ||
The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma | Q43943699 | ||
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. | Q43998981 | ||
Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis | Q44031371 | ||
Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. | Q44134120 | ||
Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis | Q44360204 | ||
Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma | Q44549287 | ||
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose | Q44783905 | ||
Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer | Q44886566 | ||
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay | Q49051437 | ||
Comprehensive allelotyping of human intrahepatic cholangiocarcinoma. | Q53322004 | ||
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. | Q53362194 | ||
A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. | Q53409005 | ||
Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. | Q53635649 | ||
Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | Q53649713 | ||
Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer | Q73773615 | ||
Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features | Q74237378 | ||
Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis | Q74603356 | ||
P433 | issue | 27 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cholangiocarcinoma | Q124292 |
Liver fluke | Q1326939 | ||
liver fluke-related cholangiocarcinoma | Q19000504 | ||
P304 | page(s) | 4338-4344 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma | |
P478 | volume | 12 |
Q34978321 | Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. |
Q39328328 | Copy number profiling of tumor suppressor genes in head and neck cancer |
Q39720644 | Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma |
Q34508893 | Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand |
Q38188515 | Genomic and transcriptional alterations of cholangiocarcinoma |
Search more.